# Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

> **NCT06605612** · — · ENROLLING_BY_INVITATION · sponsor: **LMU Klinikum** · enrollment: 108 (estimated)

## Conditions studied

- Inclusion Body Myositis
- Myotonic Dystrophy
- Limb-girdle and Facioscapulohumeral Muscular Dystrophies
- Pompe Disease
- Myasthenia Gravis
- Lambert-Eaton-Syndrome
- Amyotrophic Lateral Sclerosis
- Spinal Muscular Atrophy
- Guillain-Barré Syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy
- Friedreich Ataxia
- Hereditary Motor Sensory Neuropathy

## Interventions

- **DIAGNOSTIC_TEST:** FBIndex

## Key facts

- **NCT ID:** NCT06605612
- **Lead sponsor:** LMU Klinikum
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-09
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06605612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06605612, "Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06605612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*